Dr Alison Krentel
BA MScPH PhD
Honorary Research Fellow
I studied Art and English at Washington and Lee University in Virginia. In my early career I focused on developing promotional materials to support mass media campaigns for HIV/AIDS in Gabon and Indonesia. From that grew an interest in working with communities and health workers to better understand how to engage them in health programmes. My postgraduate work was completed at LSHTM: a MSc in Public health in developing countries (1999) and a PhD in Public Health in 2007.
I am the Module Organiser for Issues in Public Health in the Distance Learning (DL) Masters Programme. Also in the DL programme, I am a tutor for the Health Promotion Practice course, Controlling Communicable Disease course and I supervise student research projects.
My research interests include how to best facilitate community engagement in the execution of public health programmes, conducting implementation research so as to support health systems in infectious disease control programmes and understanding how best to translate research results into programmatic action. I am also interested in how to mobilise, motivate and support community health volunteers. Specific disease areas include: lymphatic filariasis, leishmaniasis and other NTDs, malaria, HIV/AIDS.
In collaboration with Universitas Indonesia and Reflecting Society Pty Ltd we tested the use of a health survey using micronarratives (stories) as a means of capturing experiences with health programmes from the perspective of the community member as well as the health worker. Guidelines for use of micronarratives in health research can be found through the NTD Support Center website.
Recently I was part of a larger community based safety trial coordinated by Washington University in St Louis and the NTD Support Center at the Task Force for Global Health and funded by the Bill and Melinda Gates Foundation. Together with national research institutions we ascertained levels of acceptability of a new treatment regimen for lymphatic filariasis in Haiti, India, Indonesia, Fiji and Papua New Guinea amongst community members, community drug distributors and frontline health workers.